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ABSTRACT
Intestinal microbiota regulates multiple host metabolic and immunological processes. 
Consequently, any difference in its qualitative and quantitative composition is susceptible to 
exert significant effects, in particular along the gut-liver axis. Indeed, recent findings suggest that 
such changes modulate the severity and the evolution of a wide spectrum of hepatobiliary 
disorders. However, the mechanisms linking intestinal microbiota and the pathogenesis of liver 
disease remain largely unknown. In this work, we investigated how a distinct composition of the 
intestinal microbiota, in comparison with germ-free conditions, may lead to different outcomes in 
an experimental model of acute cholestasis. Acute cholestasis was induced in germ-free (GF) and 
altered Schaedler’s flora (ASF) colonized mice by common bile duct ligation (BDL). Studies were 
performed 5 days after BDL and hepatic histology, gene expression, inflammation, lipids metabo-
lism, and mitochondrial functioning were evaluated in normal and cholestatic mice. Differences in 
plasma concentration of bile acids (BA) were evaluated by UHPLC-HRMS. The absence of intestinal 
microbiota was associated with significant aggravation of hepatic bile infarcts after BDL. At base-
line, we found the absence of gut microbiota induced altered expression of genes involved in the 
metabolism of fatty and amino acids. In contrast, acute cholestasis induced altered expression of 
genes associated with extracellular matrix, cell cycle, autophagy, activation of MAPK, inflammation, 
metabolism of lipids, and mitochondrial functioning pathways. Ductular reactions, cell proliferation, 
deposition of collagen 1 and autophagy were increased in the presence of microbiota after BDL 
whereas GF mice were more susceptible to hepatic inflammation as evidenced by increased gene 
expression levels of osteopontin, interleukin (IL)-1β and activation of the ERK/MAPK pathway as 
compared to ASF colonized mice. Additonally, we found that the presence of microbiota provided 
partial protection to the mitochondrial functioning and impairment in the fatty acid metabolism 
after BDL. The concentration of the majority of BA markedly increased after BDL in both groups 
without remarkable differences according to the hygiene status of the mice. In conclusion, acute 
cholestasis induced more severe liver injury in GF mice compared to mice with limited intestinal 
bacterial colonization. This protective effect was associated with different hepatic gene expression 
profiles mostly related to tissue repair, metabolic and immune functions. Our findings suggest that 
microbial-induced differences may impact the course of cholestasis and modulate liver injury, 
offering a background for novel therapies based on the modulation of the intestinal microbiota.
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Introduction
The mammalian gut harbors billions of microorgan-
isms, including Archaea and Eukaryota, collectively 
referred as gut microbiota. There is increasing evi-
dence that humans have evolved a close symbiotic 
relationship with gut microbiota. An individual var-
iation in the gut microbial species may implicate 
several diseases. Over the last few decades a number 
of studies have shown that the gut microbiota pro-
duces a large repertoire of small molecules and con-
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tributes to important functions of host physiology 
including immunity and metabolism,1–4 digestive4 
and protective functions,5 microbial catabolism of 
otherwise indigestible nutrients,6 provision of essen-
tial amino acids, maturation of the host mucosal 
immune system,5,7 completion of the bile-salt cycle 
and pre-systemic metabolism of drugs and toxins.8–10 
The bidirectional interaction between the gut micro-
biota and the liver is established through a vascular 
route consisting of the portal vein that carries gut- 
derived metabolites to the liver, and a biliary route, 
that transports the bile from liver to the intestine.11 
Indeed, changes in intestinal bacterial composition 
and the derived metabolites play a key role in the 
pathogenesis of a number of chronic diseases includ-
ing liver disorders.12,13 The alteration in gut microbial 
composition and its subsequent effect on different 
metabolic disorders have been recently highlighted 
in numerous experimental models.14,15 For example, 
a study by Rabot et al. compared the metabolic con-
sequences of the absence of intestinal microbiota in 
mice treated with a high fat diet. Germ-free (GF) 
mice consumed less calories, excreted more fecal 
lipids and consequently their body weight was sig-
nificantly lower than colonized mice, emphasizing the 
direct effect of microbiota on energy metabolism.16 
Studies have also demonstrated that intestinal micro-
biota can influence the total energy balance equation 
and genes regulating energy expenditure.15,17 
Moreover, the absence of gut microbiota has been 
associated with a reduced BA diversity,18,19 increased 
size of the BA pool, the absence of secondary BA, 
reduced fecal excretion of BA and up-regulation of 
BA transporter genes.20,21
Bile acid transporter genes belong to two super- 
families of transporters: ATP-binding cassette (ABC) 
and solute carrier (SLC) transporters that achieve an 
important role in the canalicular secretion and trans-
port of bile and cholesterol in hepatocytes.22 The 
expression of these transporters is tightly regulated 
at the transcriptional and post-transcriptional 
levels.23 On the one hand, gut microbiota has been 
shown to play a critical role in bio-transformation of 
bile acids through deconjugation, dehydroxylation, 
and reconjugation processes.21 On the other hand, 
bile acids have antimicrobial activity which, in return, 
regulates the qualitative and quantitative composition 
of the microbiota and protects the epithelial barrier 
from damage.24 These functions are performed by 
primary or secondary bile acids, which are derived 
from bile salts.25 The bile acids have the ability to 
disrupt bacterial membranes, denature their proteins, 
and cause oxidative damage to DNA, thereby con-
trols the gut microbiota species in the host.26
The liver coordinates the storage, breakdown and 
redistribution of nutrients efficiently to meet energy 
demands in different tissues. The hepatic energy 
metabolism is tightly regulated by different meta-
bolic hormones, nutrients and neuronal signals.27 
The liver also plays a central role in the regulation 
of bile acids metabolism.28 Variations in bile acid 
flow may initiate several types of liver diseases or 
impede the progression of an existing liver disease.29
Acute cholestasis is an acute liver injury due to 
an impairment of natural flux of bile acids from the 
liver to intestine due to an obstruction to the bile 
flow through intra/extrahepatic bile ducts. This 
results to an accumulation of cytotoxic bile acids 
in the liver and plasma and causes hepatocellular 
necrosis and apoptosis, acute liver inflammation 
followed by the proliferation of bile duct epithelial 
cell, activation of hepatic stellate cells and deposi-
tion of fibrotic tissue in the liver primarily as tissue 
repair and regenerative response.30,31 However, if 
the injury persists, the liver undergoes a sustained 
wound healing response where regeneration, 
inflammation and tissue remodeling occurs in 
a vicious circle leading to the formation of fibrotic 
scars and ultimately liver fibrosis.32,33
The impairment of bile flow to the intestine has 
also been reported to result in metabolic disorders 
modulated by the microbiota and associated with the 
occurrence of cholestasis.34,35 However, mechanisms 
underpinning the potential role of microbiota 
mediated pathogenesis and progression of cholestatic 
liver disease is not well understood. Therefore, in this 
study, we aimed to characterize the changes in hepa-
tic gene expression profile and plasma BA composi-
tion modulated by varying microbial colonization 
under basal conditions and in acute cholestasis.
Materials and Methods
Animals
Male C57BL/6, aged 10–12 weeks, GF (germ-free) 
and ASF (altered Schaedler’s flora) mice were gener-
ated in Clean Mouse Facility (CMF) of University of 
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Bern. The ASF mice contains eight bacterial species 
including Lactobacillus acidophilus, Lactobacillus 
murinus, Bacteroides distasonis, Mucispirillum schae-
dleri, Eubacterium plexicaudatum, a Fusiform-shaped 
bacterium and two Clostridium species and has the 
advantage to limit the possible experimental variabil-
ity that can be expected with specific pathogen-free 
mice (SPF). Mice were born and maintained in flex-
ible film isolators under HEPA air and fed with 
autoclaved chow and water ad libitum. All animals 
were kept on a 12-hour dark/light cycle. All experi-
mental protocols obtained the approval of the 
Research Animal Ethics Committee of Canton Bern 
(BE66/10). All experiments were performed accord-
ing to international guidelines concerning the con-
duct of animal experimentation.
Induction of acute cholestasis by common bile duct 
ligation
As described previously,36 the mice received 60 µg/ 
kg body weight of buprenorphine subcutaneously 
(Reckitt Benckiser, 0.3 mg/ml) before the surgery. 
Midline laparotomy was performed under isoflur-
ane anesthesia. The bile duct was isolated from the 
surrounding tissues, and a 7–0 silk ligature was tied 
at proximal and distal end to the liver hilus. Finally, 
the bile duct was resected between the two ligatures. 
In sham-operated animals, the bile duct was only 
isolated but not ligated. The animals were sacrificed 
5 days after BDL, plasma and tissues were collected 
for further experiments.
Liver histology and image analysis
Segments of liver tissue samples were fixed in 4% 
buffered formalin, embedded in paraffin blocks and 
tissue slides were prepared for standard histology. 
The 5 µm sections were used for hematoxylin and 
eosin (H&E) staining for routine examination and 
quantification of bile infarcts as well as Sirius red 
staining for determination of fibrotic tissue in the 
liver. The quantification of bile infarcts was per-
formed using MetaMorph imaging software (NX 
software 64-bite, version 7.8.12.0). The focal necro-
sis surface for the whole liver section area was 
evaluated blindly from different randomly chosen 
field of areas.
Multiplex fluorescence immunostaining
In-depth cell phenotyping was performed with mul-
tiplex immunostaining as described elsewhere.37 
Briefly sequential immunostaining and antibody 
stripping was performed on 4 µm-thick formalin- 
fixed paraffin embedded liver tissue sections 
obtained from all experimental groups (n = 3/ 
group). After deparaffinization with xylene, all tissue 
sections underwent repetitive cycles of antigen 
retrieval (Tris-EDTA, pH 9.0, Novus Biologicals, 
Centennial, CO, USA) for 30 minutes in water 
bath and antibody stripping using 2-mercaptoetha-
nol/SDS as described previously.38 To avoid nonspe-
cific antibody binding the sections were incubated 
with 2.5% horse serum (Vector BioLabs, Malvern, 
PA, USA), for 1 h at room temperature for the first 
round of staining. Afterward, the sections were incu-
bated overnight at 4°C with primary antibodies 
(Supplementary table 1S). Whole scanning of sec-
tions was performed using Zeiss Axio Observer 7 
followed by stitching and background subtraction. 
The scans were aligned, hyperstacks and concate-
nated using FIJI HyperStackReg V5.6 plugin. The 
image segmentation was performed on all binary 
images using Ilastik software (v 1.3.3). CellProfiler 
v3.1.9 was used for cell identification, counting and 
intensity measurement.
RNA extraction and mRNA sequencing
Total RNA was extracted from 30 to 50 mg of 
frozen liver tissues using the RNeasy Plus Mini 
Kit (Qiagen), as described in manufacturer’s 
instructions. RNA was eluted in 30 μl of RNase 
and DNase free water. The quantity and quality of 
the extracted RNA was assessed by checking the 
RNA integrity number (RIN) using the Agilent 
2100 bioanalyzer. The concentration of RNA was 
evaluated using Agilent RNA 6000 Nano kit (-
5067–1512). Total RNA concentration of 1–2 µg 
was used for mRNA sequencing (Illumina Hiseq 
2500). The NGS reads were mapped to the mouse 
reference genome mm10) with Tophat v.2.0.13.39 
We used htseq-count v.0.6.1 to count the number 
of reads overlapping with each gene as specified in 
the Ensembl annotation release 75.40 The number 
of reads per gene were compared between the dif-
ferent experimental groups using DESeq2 v.1.6.3.41 
GUT MICROBES e1911534-3
P-values were FDR adjusted using the procedure of 
Benjamini and Hochberg 1995.42 All gene expres-
sion volcano plots were generated using ggplot 
package in R. Genes with an absolute log fold 
change > 2 and adj-p value < .05 were considered 
significant. Furthermore, known and predicted 
interactions for differentially regulated genes were 
derived using the STRING database.43
Gene expression analysis by real-time quantitative 
PCR
Liver or small intestine sections of 30 to 40 mg were 
used to extract RNA with the RNeasy Plus Mini Kit 
(Qiagen) and total RNA was quantified using 
NanoDrop™ OneC (ThermoFisher). cDNA was 
obtained by reverse transcription of 0,15 µg of 
RNA using M-MLV Reverse Transcriptase 
(ThermoFisher) and oligo (dT) primers. qPCR 
reactions were performed using predesigned probes 
and primers (Supplementary table 1S) and 
TaqMan™ Fast Universal PCR Master Mix 
(ThermoFisher) in a QuantStudio™ 3 Real-Time 
PCR System (ThermoFisher) according to the man-
ufacture’s protocol. CT values were normalized to 
18S ribosomal RNA housekeeping gene and repre-
sented as relative fold change to the corresponding 
control condition (2−ΔΔCt).
Protein gel electrophoresis and Immunoblot 
Analysis
Frozen liver tissues were thawed and washed twice 
with ice-cold PBS. Livers were homogenized with 
0.5 mm zirconium oxide beads (Next Advance, 
Troy, NY, USA) in a bullet blender (Next 
Advance, Troy, NY, USA) in RIPA buffer 
(150 mM NaCl, 1% NP-40, 0.5% Na-deoxycholate, 
0.1% SDS, and 50 mM Tris-HCl, pH 7.4) contain-
ing Halt™ protease and phosphatase inhibitor 
(Thermo Fisher Scientific, Rockford, IL, USA). 
Protein concentration was measured with the 
PierceTM BCA assay (Thermo Fisher Scientific, 
Rockford, IL, USA). 15 µg of total lysate was loaded 
into 10–12% sodium dodecyl sulfate polyacryla-
mide gel and proteins were resolved by electro-
phoresis. The proteins were transferred to 
nitrocellulose membranes, blocked for 1 h with 
5% nonfat milk, and then incubated overnight at 
4°C with primary antibodies (Supplementary table 
1S). Next, the membranes were incubated with 
peroxidase-conjugated secondary antibody 
(Thermo Fisher Scientific, Rockford, IL, USA) for 
1 h and signals were revealed with enhanced che-
miluminescence (Amersham ECL Prime, GE 
Healthcare, Glattburg, Switzerland) and a Fusion 
CCD camera coupled to a computer equipped with 
Fusion Capt Fx Software (Vilber-Lourmat, Marne- 
la-Vallée, France). Band densitometry was mea-
sured with the Bio-1D Advanced software (Vilber- 
Lourmat).
Free fatty acids measurement
Ten milligrams of liver tissue was homogenized 
and total-free fatty acids were measured in 10 mg 
of liver tissue by the fluorometric FFA kit 
(BioVision) as per the manufactured instructions.
Respirometry assay using modified Seahorse 
protocol
The oxygen consumption rates (OCRs) in homo-
genates from frozen livers were measured with 
a Seahorse Extracellular Flux (XF) -96 
Bioanalyzer (Agilent Technologies, Santa Clara, 
CA, USA). Frozen liver tissues were thawed and 
washed two times with ice-cold PBS. The 
‘Respirometry in Frozen Samples (RIFS)’ protocol 
was adapted from Acin-Perez R et al. 2020.44 
Approximately, 50 mg of tissue was cut into 
small pieces and homogenized in MAS buffer 
(70 mM sucrose, 220 mM mannitol, 5 mM KH2 
PO4, 5 mM MgCl2, 1 mM EGTA, 2 mM HEPES, 
pH 7.4) with 20 strokes in a glass Dounce homo-
genizer. The homogenate was centrifuged at 
1,000 g for 10 min at 4°C, the supernatant was 
collected and protein concentration was deter-
mined by PierceTM BCA assay (Thermo Fisher 
Scientific, Rockford, IL, USA). In Seahorse XF96 
microplate, 10 µg (proteins) of homogenate was 
loaded into in 20 µl of MAS. The loaded plate was 
centrifuged at 2,000 g for 5 min at 4°C and an 
additional 130 µl of MAS containing cytochrome 
c (10 µg/ml) was added to each well. Substrates 
were delivered by port A (pyruvate + malate 
(5 mM each)) or NADH (1 mM), or 5 mM succi-
nate + rotenone (5 mM + 2 µM). The inhibitors, 
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Rotenone and antimycin A (2 µM + 4 µM) were 
delivered by port B. TMPD + ascorbic acid 
(0.5 mM + 1 mM) at port C; and azide (50 mM) 
at port D.
Metabolomics
The blood samples were obtained from the inferior 
vena cava of sham and BDL mice both in GF and 
ASF colonized mice. The plasma was then extracted 
and frozen immediately at −80°C for longer sto-
rage. The plasma samples from all mentioned 
groups were used for metabolomics study as 
described below in Section UHPLC-HRMS 
Analyses.
Bile acid extraction
Deuterated chenodeoxycholic acid (CDCA) and 
deoxycholic acid (DCA) were used as recovery 
standards in this study.45 30 µl of the collected 
plasma (duplicates) from all experimental groups 
mixed with 10 µl of recovery standard solution 
(CDCA-D4 100 µM). Then, an amount of 100 µl 
of ice cold alkaline (5% NH4OH in ACN) was 
added and vortexed 1 min equally for all samples 
and continuously shaken for 1 hour at room tem-
perature. The mixture was then centrifuged at 
16,000 g for 10 minutes. The supernatant was col-
lected and freeze-dried in a rotational vacuum con-
centrator overnight. Subsequently, the extracts 
were reconstituted in 80 µl of ammonium acetate 
(5 mM): methanol pH 6 and were kept in −20°C 
until LC-MS injection.
UHPLC-HRMS Analyses
We performed qualitative and quantitative ana-
lyses of the plasma concentration of BA on an 
Agilent 6530 Accurate-Mass Q-TOF LC/MS 
mass spectrometer coupled to an Agilent 1290 
series UHPLC system (Agilent Technologies, 
USA), as described elsewhere.45 Sample separation 
was performed using a Zorbax Eclipse-Plus C18 
column (2.1 × 100 mm, 1.8 µm; Agilent 
Technologies, USA) heated at 50°C.5 mM ammo-
nium acetate (pH 6) in water was used as eluent 
A and acetonitrile as eluent B in a binary gradient 
system. The detection in the mass spectrometer 
was operated in negative ionization mode using 
the Dual AJS Jet stream ESI Assembly. During 
acquisition the internal calibration was performed 
by infusing continuously the reference mass solu-
tion 5 mM purine, 1 mM HP-921 (Agilent refer-
ence mass kit, Agilent Technologies USA) in 95% 
MeOH acidified with 0.1% formic acid and 
allowed to permanently achieve a mass accuracy 
better than 5 ppm. HR mass spectra were acquired 
over the range of m/z 300–700 at an acquisition 
rate of three spectra/s. The data was processed 
using the Mass Hunter Workstation (Agilent 
Technologies, USA). Extracted ions chromato-
grams (XIC) were based on a retention time 
(RT) window of ±0.5 min with a mass extraction- 
windows (MEW) of ±30 ppm centered on m/ztheor 
of each bile acid.
Statistical analysis
Statistical analyses were performed using GraphPad 
Prism 5 (GraphPad Software Inc., California, USA). 
Comparisons between two groups were performed 
using Mann- Whitney’s U test. Multiple compar-
isons were performed using a one-way ANOVA 
followed by a Kruskal-Wallis test. Data are reported 
as mean ± SD. Differences were considered signifi-
cant at <0.05. The FDR correction in NGS data was 
calculated according to Benjamini and Hochberg, 
1995.42
Results
Absence of intestinal microbiota results in larger 
bile infarcts area and less ductular reactions in 
acute cholestasis
To evaluate the extent of liver damage upon BDL, 
liver sections from experimental groups of mice 
were stained with hematoxylin and eosin (H&E). 
The intrahepatic accumulation of bile after BDL 
resulted in bile infarcts in both groups; GF-BDL 
and ASF-BDL mice (Figure 1a). However, the size 
of bile infarct areas was significantly greater in GF 
cholestatic mice as compared to ASF cholestatic 
mice (Figure 1b). To confirm the effect of choles-
tasis in GF and ASF-BDL mice, we performed 
multiplex immunostaining of CK-19 (Figure 1c). 
We observed a significant increase in CK-19 
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positive biliary cells in response to BDL in both 
GF and ASF mice as compared to their respective 
sham-operated mice. However, mice with micro-
biota showed more ductular reactions after acute 
cholestasis than mice without microbiota 
(Figure 1d).
Acute cholestasis differentially alters hepatic gene 
expression according to the presence or absence of 
intestinal microbiota
To analyze the different response to acute choles-
tasis depending on hygiene status, hepatic gene 




Figure 1. Acute cholestasis induce the formation of bile infarcts and ductular reactions in the liver of ASF and GF mice. (A) 
Representative H&E staining images at 10x magnification showing the formation of bile infarcts in liver sections of ASF and GF 
mice after 5 days of BDL. (B) Bile infarct area quantification (percentage pixel area) in liver sections of ASF and GF mice after 5 days of 
BDL. (C) Representative images of multiplex immunostaining of CK-19 in liver sections of all experimental groups and (D) quantification 
of positive CK-19. Data are expressed as mean ± SD. n=3/group. *p<0.05, **p<0.01, ***p<0.001. Abbreviations: ASF; altered 
Schaedler’s flora, GF; germ free, H&E; hematoxylin and eosin, CK-19; cytokeratin-19, SD; standard deviation. 
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transcriptomic analysis. The comparison was per-
formed between the groups with distinct micro-
biota, in acute cholestasis and at baseline. Among 
the total of 4445 differentially expressed genes 
(DEGs), we observed 1520 genes were differentially 
expressed only in the comparison of ASF-BDL to 
ASF-sham, 915 genes only in the comparison of 
GF-BDL to GF-sham and 2010 genes in both over-
lapped between ASF-BDL and GF-BDL (Figure 2a). 
The Pathway enrichment analysis was further per-
formed in different combinations across all experi-
mental groups to find the functions of these DEGs 
(Figure 2b).
Absence of intestinal microbiota significantly alters 
hepatic gene expression at baseline
At baseline we found that 78 genes were differen-
tially regulated when GF mice were compared to 
ASF mice (Supplementary figure 1S). Among those 
differentially regulated, 54 genes associated with the 
functions of fatty acid metabolism, circadian clock, 
autophagy, purine biosynthesis, cytochrome P450, 
lysosomal functions and glycogen metabolism were 
significantly downregulated at baseline in GF-sham 
vs ASF-sham (Figure 3a), and 24 genes associated 
with purine metabolism, circadian functions, DNA 
methylation, amino acid metabolism, and mito-
chondrial functions were significantly upregulated 
in GF-sham mice when compared to ASF-sham 
mice (Figure 3b). The details of the differentially 
regulated genes are shown in Supplementary 
table 2S.
Acute cholestasis significantly alters hepatic gene 
expression in the presence of microbiota associated 
with increased tissue repair response
We identified 1520 DEGs induced by acute choles-
tasis in ASF mice compared to controls. Among 
these 1520 genes, 716 genes were significantly 
downregulated, and 804 genes were significantly 
upregulated in ASF-BDL when compared to ASF- 
sham (Supplementary figure S2A). Pathway enrich-
ment analysis revealed that the downregulated 
genes were mainly involved in the regulation of 
the innate immune system, complement activation, 
fatty acid biosynthesis/metabolism, GPCR 
signaling, AKT signaling, xenobiotic metabolism 
and ABC transporter expression (Figure 4a). The 
upregulated genes were mainly associated with 
extracellular matrix remodeling, angiogenesis, 
actin binding, lipid and glucose metabolism, 
MAPK-ERK pathway activation, DNA damage/ 
apoptosis, and GPCR signaling (Figure 4b). The 
details of the differentially regulated genes are 
shown in Supplementary table 3S.
Next, we evaluated the expression of genes 
involved in extracellular matrix (ECM), cell prolif-
eration and autophagy pathways enriched in BDL 
conditions. We measured the expression of col-
lagen-1 (Col1) and proliferating cell nuclear anti-
gen (PCNA) by Multiplex immunostaining in liver 
sections to further validate NGS data (Figure 4c). 
We observed a significant increase in the expres-
sion of the these markers after acute cholestasis in 
both GF and ASF mice as compared to sham- 
operated animals. However, the expression of 
these genes found to be significantly lower in GF- 
BDL than ASF-BDL (Figure 4d-e). Increased 
deposition of hepatic collagen in response to acute 
cholestasis was further confirmed by Sirius red 
staining and the results were in line with RT- 
qPCR and NGS data that expression of Col1 
increased after BDL but this increase was more in 
ASF-BDL as compared to GF-BDL (Supplementary 
figure S2B).
To evaluate the effect of acute cholestasis on 
autophagy, we examined p62-mediated autophagy 
by measuring levels of p62 and phosphorylated-p62 
(p_p62) in liver homogenates by WB (figure 4f). 
The expression levels of p62 remains similar among 
all experimental groups (figure 4f) but the expres-
sion of p_p62 was significantly increased in ASF- 
BDL when compared to the ASF-sham and GF- 
BDL suggesting an activation of this pathway dur-
ing acute cholestasis in the presence of microbiota 
(Figure 4g).
Absence of microbiota significantly alters hepatic 
gene expression in response to acute cholestasis 
associated with increased hepatic inflammation
Among the 915 differentially expressed genes, 464 
genes were significantly downregulated, and 451 




Figure 2. Transcriptomic analysis of liver samples from sham-operated or BDL mice with or without microbiota. (A) Venn diagram 
showing the total number of DEGs after acute cholestasis in ASF and GF mice as compared to baseline. The figure also demonstrates
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when compared to GF-sham (Supplementary figure 
3S). Pathway enrichment analysis revealed that the 
downregulated genes were mainly associated with 
energy/protein metabolism, xenobiotic metabolism 
by cytochrome P450, oxidative phosphorylation, 
bile secretion, immune cell development, DNA 
damage/autophagy, coagulation, protein proces-
sing and transport (Figure 5a). While the upregu-
lated proteins were associated with the functions of 
chemotaxis, complement activation, inflammation, 
MAPK activation/cell proliferation, choline meta-
bolism, apoptosis/autophagy, innate immune sys-
tem, chromatin modification, and cell cycle (Figure 
5b). The details of the differentially regulated genes 
are shown in Supplementary table 4S.
In order to validate the data obtained from the 
pathways enrichment post BDL in the absence of 
microbiota, we first evaluated the activation of the 
MAPK signaling by measuring ERK, p38 and its 
phosphorylated form in liver homogenates by WB 
(Figure 5c). Phosphorylation of ERK and levels of 
p38 were significantly increased after acute choles-
tasis only when microbiota was absent (Figure 5d). 
We then assessed hepatic inflammation by measur-
ing proinflammatory cytokines with RT-qPCR to 
confirm results obtained from NGS. Gene expres-
sion of proinflammatory markers (IL-1β, IL-6, 
SPP1, TNF-⍺) were significantly increased in 
response to acute cholestasis in the presence and 
absence of intestinal microbiota (Figure 5e). In line 
with MAPK activation, mRNA expression of IL-1β 
and SPP1 were significantly upregulated in the 
absence of microbiota when compared to ASF- 
BDL suggesting that mice without microbiota are 
the overlap of DEGs in GF and ASF after 5 days of BDL as compared to baseline. The DEGs with p<0.05 were considered significant, 
n=3/group. (B) Heat map showing an overview of differentially expressed gene sets with their associated biological pathways in GF vs 
ASF (hygiene status) before and after acute cholestasis. Blue color represents a lower and red color represents a higher expression level. 
Abbreviations: GF; germ free, ASF; altered Schaedler’s flora, BDL; bile duct ligation, DEG; differentially expressed genes.
Figure 3. Transcriptome analysis of GF-sham vs ASF-sham. (A and B) Pathway enrichment analysis of hepatic transcriptome data, Go 
enrichment analysis for biological processes among differentially regulated genes in ASF vs GF mice at baseline. p<0.05, n=3/group. 
Abbreviations: GO; gene ontology, ASF; altered Schaedler’s flora, GF; germ free. 
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Figure 4. Transcriptome analysis of ASF-BDL vs ASF-sham reveals an increased regenerative response to the liver injury in mice with 
microbiota. (A and B) Pathway enrichment analysis of transcriptome data, Go enrichment analysis for biological processes among
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more susceptible to liver inflammation after acute 
hepatic injury.
Acute cholestasis alters hepatic gene expression 
associated with reduced lipid metabolism and 
mitochondrial respiration and gut microbes provide 
partial protection
We next compared only differentially expressed 
genes and their functional association (an effect of 
cholestasis) in ASF-BDL compared to GF-BDL 
mice. Among the 112 genes that were differentially 
expressed, 63 genes were significantly downregu-
lated while 49 genes were significantly upregulated 
as shown in (Supplementary figure S4A). Pathway 
enrichment analysis showed that the downregu-
lated genes were associated with the functions of 
lipid and cholesterol metabolism, protein binding/ 
homodimerization, cell adhesion, protease binding, 
bile acid metabolism, and Wnt/Cadherin signaling 
(Figure 6a), while the upregulated genes were asso-
ciated with processes such as NADH dehydrogen-
ase activity, cell division/cell cycle, extracellular 
matrix, angiogenesis, platelet activation, and actin 
polymerization (Figure 6b). The details of the dif-
ferentially regulated genes are shown in 
Supplementary table 5S.
Fatty acid metabolism in the liver is impaired 
due to cholestasis.46,47 We also found enrichment 
of fatty acid metabolic pathways in our mRNA 
sequencing data while assessing the effect of BDL 
in liver (Figure 6c). Reduced expression of genes 
related to lipid metabolism after liver damage was 
validated by RT-qPCR (Supplementary figure S4B- 
D). We measured by WB the hepatic protein 
expression of ATP citrate lyase (ATPCL) that 
forms acetyl-CoA in cytosol as a precursor of lipo-
genesis, fatty acid synthase (FAS) that regulates the 
production of long-chain fatty acids from acetyl- 
CoA and the solute carrier family 27 member 2 
(SLC27A2) that participates in the transport and 
uptake of fatty acids in the liver (Figure 6d). 
Expression of ATPCL was significantly reduced 
after BDL in both, ASF and GF mice. FAS and 
SLC27A2 expressions were also decreased after 
acute cholestasis but only significantly in animals 
without microbiota compared to sham-operated 
mice (Figure 6e). As expected, levels of free fatty 
acids (FFA) were reduced in both conditions after 
BDL but only signficanlty in ASF condition (figure 
6f). Of note that levels of FFA at the baseline were 
significantly lower in the absence of microbiota 
underlining regulatory role of microbiota in lipid 
metabolism (figure 6f).
In mRNA sequencing data, we also found 
significantly enriched pathways related to mito-
chondrial bioenergetics while comparing ASF- 
BDL to GF-BDL (Figure 2b). Therefore, we mea-
sured mitochondrial mass and activities of its 
respiratory complexes (mitochondrial respiration 
complex I, complex II and complex IV activities) 
using Seahorse Extracellular Flux (XF) -96 
Bioanalyzer in liver homogenates (Figure 6g-i). 
Our results demonstrated that in GF-BDL mice 
the pyruvate and malate-dependent basal 
respiration increased as compared to the GF- 
sham (Figure 6j). BDL in both groups, ASF 
and GF led to reduced activity of complex 
I but ASF-BDL had higher complex I activity 
than GF-BDL (Figure 6j). Further, the complex 
II activity was reduced in ASF-BDL compared to 
ASF-sham however; the absence of gut micro-
biota did not affect the complex II activity in 
sham or BDL groups (Figure 6j). Complex IV 
activity was measured independently, using the 
substrates TMPD/ascorbic acid and showed that 
BDL resulted to reduced activity of complex IV 
in both, ASF and GF mice compared to sham 
groups (Figure 6j). To determine whether the 
mitochondrial mass could be attributed to the 
reduction in the activity of respiratory com-
plexes, we quantified mitochondrial proteins 
cytochrome c oxidase (COX) IV, translocase of 
outer mitochondrial membrane 20 (TOMM 20) 
differentially regulated genes in ASF-BDL vs ASF-sham. p<0.05, n=3/group. (C) Representative images of multiplex immunostaining of 
Col-1 and PCNA in liver sections of all experimental groups and (D-E) corresponding quantifications. (F) Immunoblots of p62 and p_p62 
in liver homogenates from ASF and GF groups followed by (G) quantification. GAPDH served as a loading control. Data are expressed as 
mean ± SD. n=3/group. *p<0.05, **p<0.01, ***p<0.001. Abbreviations: GO; gene ontology, ASF; altered Schaedler’s flora, GF; germ 
free, BDL; bile duct ligation, Col-1; collagen 1, PCNA; proliferating cell nuclear antigen, p_p62; phosphorylated p62, GAPDH; 
glyceraldehyde 3-phosphate dehydrogenase; ns; not significant, SD; standard deviation.
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Figure 5. Transcriptome analysis of GF-BDL vs GF-sham shows increased hepatic inflammation after acute cholestasis in GF mice. (A 
and B) Pathway enrichment analysis of transcriptome data, Go enrichment analysis for biological processes among differentially
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and voltage-dependent anion channel 1 
(VDAC1) in liver homogenates (Figure 6k). We 
found no difference in the expression of these 
proteins nor in ASF and GF shams neither in 
BDL groups indicating that the changes in the 
mitochondrial respiration are not due to the 
mitochondrial abundance but rather to its activ-
ity in our model of acute cholestasis (Figure 6l).
Acute cholestasis results in increased concentration 
of primary BA independent of distinct microbiota
We next investigated whether the hygiene status 
and acute cholestasis affect the plasma metabolo-
mic profile in mice. The principal component ana-
lysis is shown in Figure 7a. Under basal conditions, 
there were no significant differences in primary BA 
concentrations between GF and ASF mice. The 
concentration of the majority of BA markedly 
increased in acute cholestasis in both groups. 
However, we observed that the concentration of 
bMCA and tauro-conjugated primary bile acids 
like TCA3S, TbMCA, TUDCA, TCDCA, THCA, 
TCA were remarkably higher only in cholestasis 
without remarkable differences related to the 
hygiene status of the mice (Figure 7b).
Discussion
In this study, we investigated the effects of distinct 
microbial colonization on hepatic gene expression 
in response to liver damage using an experimental 
model of acute cholestasis. We demonstrated here 
that gut microbes provide a partial protection to 
acute cholestasis induced by BDL associated with 
reduced regions of bile infarcts, increased regenera-
tive/tissue repair response of the liver, balanced 
hepatic inflammation, and lipid metabolism as 
well as mitochondrial respiration while compared 
to GF mice. We have also identified by next gen-
eration sequencing sets of genes that were differen-
tially expressed according to the presence or 
absence of intestinal microbiota, and with or with-
out cholestasis.
Previously, Mazagova et al showed that the 
absence of microbiota was associated with 
increased liver fibrosis in chronic models of liver 
injury.48 In line with this data, Tabibian et al 
demonstrated severe biliary injury was associated 
with increased ductular reactions, fibrosis, ducto-
penia and cholangiocyte senescence in mdr−/- 
knockout mice under GF conditions.49 In 
a similar manner, we have also recently demon-
strated a hepato-protective effect of complex micro-
biota in two different experimental models of liver 
disease.36 Mice lacking intestinal microbiota have 
more severe phenotype associated with metabolic 
functions, deficiencies in some of the vital vitamins 
and an immature immune system.50,51 Therefore, 
the results presented here reinforce the notion that 
in the absence of intestinal microbiota, acute cho-
lestasis is associated with increased hepatic damage 
and metabolic dysfunction.
The increased susceptibility of GF mice to 
acute cholestasis was primarily evidenced when 
we observed that survival rate in GF-BDL mice 
drastically reduced (Supplementary Figure 5S) 
which further confirmed with larger regions of 
bile infarcts observed in GF compared to ASF- 
colonized mice. To investigate whether differ-
ences in intestinal microbial colonization during 
acute cholestasis may influence the expression of 
hepatic genes, we studied gene expression pro-
files in liver samples from GF and ASF mice at 
baseline and in acute cholestasis. We observed 
differentially expressed gene sets involved mainly 
in ECM, cell cycle, autophagy, activation of 
MAPK, inflammation, metabolism of lipids and 
mitochondrial functioning pathways being dif-
ferentially affected according to the mice hygiene 
status. We therefore characterized our model and 
investigated the most relevant pathways in 
details. We found that mice were more respon-
sive to acute liver injury in the presence of 
regulated genes in GF-BDL vs GF-sham. p<0.05, n=3/group. (C) Immunoblots of ERK and p38 and their phosphorylation in liver 
homogenates from all experimental groups followed by (D) corresponding quantification. GAPDH served as a loading control. (E) Liver 
proinflammatory markers including IL-1β, IL-6, SPP1 and TNF⍺ measured by RT-qPCR. Data are expressed as mean ± SD. n=3/group. 
*p<0.05, **p<0.01, ***p<0.001, **** p<0.0001. Abbreviations: GO; gene ontology, ASF; altered Schaedler’s flora, GF; germ free, BDL; 
bile duct ligation, ERK; extracellular signal-regulated kinase, p_ERK; phosphorylated ERK, GAPDH; glyceraldehyde 3-phosphate 
dehydrogenase, IL; interleukin, SPP1; osteopontin, TNF⍺; tumor necrosis factor, ns; not significant, SD; standard deviation.
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Figure 6. Transcriptome analysis of ASF-BDL vs GF-BDL shows that BDL affects lipid metabolism and mitochondrial functioning. (A and 
B) Pathway enrichment analysis of transcriptome data, Go enrichment analysis for biological processes among differentially regulated 
genes in ASF-BDL vs GF-BDL. p<0.05, n=3/group. (C) Gene expression of fatty acid metabolic genes significantly different between ASF- 
BDL and GF-BDL (p<0.05). (D) Immunoblots of fatty acid synthesis proteins in liver homogenates from all experimental groups followed 
by (E) quantification. GAPDH served as a loading control. (F) FFAs levels in liver homogenates from all groups included in the study. (G 
to J) Measurement of Complex I, II, and IV activity in liver homogenates in ASF and GF mice in BDL-induced acute cholestasis: Seahorse
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microbiota as evidenced by increased ductular 
structures, hepatocyte proliferation, deposition 
of Col-1 and activated autophagy indicating an 
increased hepatic regenerative response 5 days 
after acute cholestatic. Ductular reactions in 
early stages after injury reflect liver regenerative 
response to compensate loss of biliary and hepa-
tocyte cell populations.52 Increased DNA synth-
esis detected by staining of PCNA in ASF-BDL 
represents increased hepatocyte proliferation 
associated with greater liver regeneration in the 
presence of microbiota. Similarly, enhanced 
expression of Col-1 and p_p62 (autophagy) 
observed in ASF-BDL are consistent with active 
regeneration and tissue repair process thereby 
providing hepatoprotective response during 
acute liver injury.30,53 We therefore concluded 
that the presence of gut microbiota is associated 
with early physiological wound healing and tis-
sue repair responses which are considerably 
impaired in GF mice during acute cholestasis.
As expected, hepatic inflammation was signifi-
cantly increased after BDL in the presence and 
absence of microbiota. However, we found more 
inflammation and immune responses pathways 
being altered in GF-BDL such as ERK/MAPK sig-
naling pathway. We further validated these findings 
by evaluation of gene expression levels of proin-
flammatory cytokines such as TNF-α, IL-1β, IL-6 
and SPP1 which were significantly upregulated in 
both groups but this increase was more in GF-BDL 
mice as compared to ASF-BDL. Moreover, the exa-
cerbated inflammatory reponses observed in GF 
mice may correlate to their immature and under- 
developed immune system associated with defec-
tive number and function of regulatory T cells con-
trolling proinflammatory responses.54,55 The 
overexpression of SPP1 observed in GF-BDL can 
mediate the aggravated liver injury by recruitment 
of neutrophils to the damaged area thereby induces 
necrosis by attacking stressed cells.32 GF mice 
profiles of respirometry in the homogenates of frozen livers normalized to protein levels. (G) Pyruvate and malate used as substrates, 
(H) succinate used as a substrate, (I) NADH used as a substrate. (J) Quantification of the respirometry profiles of seahorse data. (K) 
Immunoblots of mitochondrial proteins in liver homogenates from ASF and GF groups followed by (L) quantification. GAPDH served as 
a loading control. Data are expressed as mean ± SD, or as mean ± SEM where indicated. n=3/group. *p<0.05, **p<0.01, ***p<0.001. 
Abbreviations: GO; gene ontology, ASF; altered Schaedler’s flora, GF; germ free, BDL; bile duct ligation, ATPCL; ATP citrate lyase, FAS; 
fatty acid synthase, SLC27A2; solute carrier family 27 member 2, GAPDH; glyceraldehyde 3-phosphate dehydrogenase, Pyr; pyruvate, 
Mal; malate, AA; antimycin A, ROT; rotenone, TMPD/Asc; TMPD + ascorbate, Succ; succinate, NADH; nicotinamide adenine dinucleotide 
hydrogen, OCR; oxygen consumption rate, SEM; standard error of mean, CIV; mitochondrial complex IV, COX; cytochrome c oxidase, 
TOMM; translocase of outer mitochondrial membrane, VDAC; voltage-dependent anion channel, ns; not significant, SD; standard 
deviation.
Figure 7. Analysis of plasma metabolomic profile in GF and ASF 
mice shows unremarkable differences before and after acute 
cholestasis. Representative figures showing (A) Score blots show-
ing PCA of plasma samples from sham (blue), with respect to BDL 
(red). (B) Bile acid profile in ASF vs GF after acute cholestasis. 
Abbreviations: ASF; altered Schaedler’s flora, GF; germ free, BDL; 
bile duct ligation PCA; principal component analysis.
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susceptibility to aggravated inflammatory 
responses after BDL predispose them to extended 
acute liver injury, further supporting the role of gut 
microbes in alleviating liver injury.
As observed in NGS data, the expression of genes 
related to lipid metabolism and functioning of mito-
chondria were affected in our model. We further 
confirmed reduced expression of lipid metabolism- 
related genes; fatty acid-binding protein (Fabp)-1, 
fatty acid synthase (Fasn) and peroxisome prolifera-
tor-activated receptor (Ppar)-⍺ and ATPCL protein 
in response to hepatic damage in all experimental 
groups. However, the lipid metabolism found to be 
more affected in GF mice as they showed reduced 
protein expression of FAS and SLC27A2 after BDL 
and importantly reduced levels of FFA at baseline 
when compared to ASF-sham. Additionally, we eval-
uated the activity of the mitochondrial respiratory 
complexes I, II and IV to assess the capacity of mito-
chondria to produce ATP through oxidative phos-
phorylation. We found that the mitochondrial 
activity was affected more in the absence of micro-
biota after BDL. These results further support that 
energy supplies in GF mice are altered considerably 
early during liver injury and it might be associated 
with an impaired capacity of the liver to regenerate as 
reported elsewhere.56 The impact of the gut micro-
biota in the regulation of metabolic functions is still 
poorly understood. Bäckhed et al reported that in the 
absence of gut microbiota, mice have less hepatic fatty 
acids and adipose triglycerides compared to conven-
tionally-raised mice.57,58 On the other hand, Kimura 
et al have reported that intestinal bacteria can sup-
press hepatic fatty acid synthesis and reduce the accu-
mulation of lipids in adipose tissue.59 Our findings are 
in line with the study of Bäckhed and colleagues 
suggesting that hepatic metabolic functions are con-
trolled by gut microbiota.57,58 The changes in micro-
biota composition could affect the occurrence and 
development of liver disease34,60 . The observations 
by Kindt et al also demonstrated that intestinal micro-
biota promote fatty acid desaturation and elongation, 
therefore supporting its regulatory role in lipid 
metabolism.14 These data are in line with our findings 
that hepatic fatty acid metabolism is critically 
impaired in GF mice due to the absence of intestinal 
microbiota.
Bile acids are synthesized from cholesterol in the 
liver and gut microbiota plays an important role in 
bile acid metabolism and recirculation.20,61 We 
investigated whether hygiene status or acute cho-
lestasis affects the plasma bile acid profile in mice. 
The concentration of free and conjugated bile acids 
(BA profile) in plasma samples from GF and ASF 
colonized mice at baseline and after cholestasis was 
evaluated. We did not find significant differences in 
concentration of primary bile acid profile under 
basal conditions between GF and ASF mice. 
Nevertheless, we observed an increased concentra-
tion of bile acid only after acute cholestasis inde-
pendent of mice hygiene status. Limited 
colonization did not show any remarkable altera-
tion in plasma bile acid concentrations as com-
pared to GF mice. Therefore, we acknowledge that 
limited colonization (far from conventionally 
raised mice) may not be sufficient to significantly 
influence the serum bile acid profile in ASF mice in 
comparison to GF mice. Hence, this may partly 
explain the unremarkable differences of bile acid 
profile between ASF and GF mice.62
In summary, we demonstrated here that com-
plete absence of intestinal microbiota contributed 
to the severity of hepatic injury during acute cho-
lestasis. Liver injury in GF mice was associated with 
an increased inflammatory responses and impaired 
fat and energy metabolism leading to insufficient 
energy supply and therefore impaired hepatic 
regeneration. Alterations observed after BDL sug-
gest that microbial-induced differences may affect 
the course of cholestasis and modulate liver injury. 
These findings highlight the beneficial role of gut 
microbiota for the host health as well as in the early 
stage of acute cholestasis and suggest that modifica-
tions of the gut microbiota may be beneficial in 
attenuating liver injury induced by cholestasis. 
One possibility to evaluate the beneficial role of 
microbiota in acute cholestasis is to transplant 
ASF microbiota into GF-BDL mice. This may lead 
to reduced hepatic damage, inflammation and 
improved fat and energy metabolisms in GF-BDL 
mice that needs to be investigated.
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